HC 104, Third Report of Session 2013-14 - Report, Together with Formal Minutes, Oral and Written Evidence
- House of Commons - Science and Technology Committee
- TSO (The Stationery Office)
Many of the clinical trials taking place today are unregistered and unpublished meaning that the information that they generate remains invisible to both the scientific community and the public, the report 'Clinical Trials (HC 104)' looks at how this undermines public trust, slowing the pace of medical advancement and potentially putting patients at risk.
The report draws attention to the recent fall in the number of trials taking place in the UK, and although the lack of public awareness is a key issue, it also finds that the requirement for multiple governance approvals from participating NHS organisations remains the biggest barrier to setting up trials.
The report recommends that all trials conducted on NHS treatments, and all other trials receiving public funding should be prospectively registered and their results published in a scientific journal. While the focus should be on implementing this change for future trials, the Government must also do what it can to ensure that historic trials are registered and published, particularly where they have been publically funded.
The Committee also recommends that the Government take steps to facilitate a greater sharing of the raw data generated during a trial in a responsible and controlled way, with the knowledge and consent of patients.
The report calls on the Government to take its recommendations into account in ongoing discussions regarding the revision of European clinical trials legislation, and in its response to the European Medicines Agency's consultation on the release of clinical trial data which closes at the end of this month.
|Format||Paperback||Published||17 Sep 2013|
|Availability||Colour copy: 3 - 5 days||Delivery||Delivery options and charges|